Belcher Pharmaceuticals LLC. Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Belcher Pharmaceuticals LLC.

Access the complete profile.

Belcher Pharmaceuticals LLC. Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	6911 Bryan Dairy Rd Ste 210 Largo, FL 33777

Note: Revenues for privately held companies are statistical evaluations.


Belcher Pharmaceuticals LLC.'s Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Belcher Pharmaceuticals LLC.'s annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Belcher Pharmaceuticals LLC. is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Belcher Pharmaceuticals LLC. Annual Revenue and Growth Rate

Belcher Pharmaceuticals LLC.	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Belcher Pharmaceuticals LLC.'s revenues are gauged from an analysis of company filings.

Belcher Pharmaceuticals LLC.'s Income Statement (based on Industry Averages)

Belcher Pharmaceuticals LLC. P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Belcher Pharmaceuticals LLC. is developing and marketing. Belcher Pharmaceuticals LLC.'s new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
BELPROFEN Veterinary pharmaceutical preparations for the treatment of inflammation	08/18/2023
TRUPROFEN FLAVTAB Veterinary pharmaceutical preparations for the treatment of inflammation	10/15/2020
TABEPI A pharmaceutical preparation that diffuses through epithelial cells for the treatment of systemic and metabolic conditions	01/13/2017

See all trademarks and details in the Full Report.

Market Share of Belcher Pharmaceuticals LLC.'s Largest Competitors

A competitive analysis shows these companies are in the same general field as Belcher Pharmaceuticals LLC., even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Belcher Pharmaceuticals LLC.. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CORERX	Clearwater, FL	100
BELCHER PHARMACEUTICALS LLC.	Largo, FL	87
ION LABS	Largo, FL	77
BIODERM	Largo, FL	74
GROVE	Clearwater, FL	52
EMES2 PHARMACEUTICALS	Clearwater, FL	6

Future Competition: Belcher Pharmaceuticals LLC.'s Fastest Growing Competitors

These companies are in the same general field as Belcher Pharmaceuticals LLC. and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)